ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 79

A NOVEL Missense Mvk mutation in a Family with Familial Mediterranean Fever-like Disease

Ilker Karacan1, Serdal Ugurlu2, Aslihan Tolun3, Eda Tahir Turanli1 and Huri Ozdogan2, 1Department of Molecular Biology and Genetics, İstanbul Technical University, Istanbul, Turkey, 2Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey, 3Department of Molecular Biology and Genetics, Boğaziçi University, Istanbu, Turkey

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Autoinflammatory Disease and familial Mediterranean fever

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Genetics, Genomics and Proteomics - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:  Monogenic autoinflammatory diseases are mainly disorders of innate immunity and characterized by unprovoked inflammatory attacks. We studied a consanguineous family with two affected children, with an initial diagnosis of Familial Mediterranean Fever (FMF). While recurrent febrile attacks with serositis, high acute response and parental origin were consistent with FMF, disease onset before age one year, delay in growth, no mutation in MEFV and poor response to colchicine were not typical features of this disease.

Methods:  SNP genotype data for all family members were used for multipoint linkage analysis. Targeted sequencing was performed for MVK residing in one of the linked regions and seven other autoinflammation related genes, IL1RN, LPIN2, MEFV, NLRP12, NLRP3, TNFRSF1A and PSTPIP1. After the identification of the causative mutation, serum IgD and urinary mevalonic acid levels were measured.

Results:  Linkage analysis detected seven candidate regions. The largest candidate region, at 12q24.11-q24.31 (LOD=1.92), contained 191 genes. Novel homozygous c.481T>C (p.Cys161Arg) mutation in MVK, the gene responsible for Hyper IgD Syndrome (HIDS) was identified. At the protein level, cysteine at position 161 is totally conserved in mammals. Urinary mevalonic acid was not detected for either patient, and serum IgD level was slightly elevated for only one patient.

Conclusion:   We identified a novel homozygous MVK mutation in patients with a FMF-like disease but without a typical HIDS phenotype. We hypothesize that this novel mutation underlies the atypical clinical presentation. Phenotypic variability of HIDS is well known, and our findings further expand the MVK mutation phenotype.


Disclosure: I. Karacan, None; S. Ugurlu, None; A. Tolun, None; E. Tahir Turanli, None; H. Ozdogan, None.

To cite this abstract in AMA style:

Karacan I, Ugurlu S, Tolun A, Tahir Turanli E, Ozdogan H. A NOVEL Missense Mvk mutation in a Family with Familial Mediterranean Fever-like Disease [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/a-novel-missense-mvk-mutation-in-a-family-with-familial-mediterranean-fever-like-disease/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-novel-missense-mvk-mutation-in-a-family-with-familial-mediterranean-fever-like-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology